608 related articles for article (PubMed ID: 11039898)
61. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
Hengstschläger M; Hölzl G; Hengstschläger-Ottnad E
Oncogene; 1999 Jan; 18(3):843-8. PubMed ID: 9989838
[TBL] [Abstract][Full Text] [Related]
62. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
63. Mitogen requirement for cell cycle progression in the absence of pocket protein activity.
Foijer F; Wolthuis RM; Doodeman V; Medema RH; te Riele H
Cancer Cell; 2005 Dec; 8(6):455-66. PubMed ID: 16338659
[TBL] [Abstract][Full Text] [Related]
64. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells.
Gao CF; Ren S; Wang J; Zhang SL; Jin F; Nakajima T; Ikeda M; Tsuchida N
Oncogene; 2002 Oct; 21(49):7569-79. PubMed ID: 12386819
[TBL] [Abstract][Full Text] [Related]
65. The E2F1-3 transcription factors are essential for cellular proliferation.
Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
[TBL] [Abstract][Full Text] [Related]
66. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity.
Callaghan DA; Dong L; Callaghan SM; Hou YX; Dagnino L; Slack RS
Dev Biol; 1999 Mar; 207(2):257-70. PubMed ID: 10068462
[TBL] [Abstract][Full Text] [Related]
67. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
68. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.
Hurford RK; Cobrinik D; Lee MH; Dyson N
Genes Dev; 1997 Jun; 11(11):1447-63. PubMed ID: 9192872
[TBL] [Abstract][Full Text] [Related]
69. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
[TBL] [Abstract][Full Text] [Related]
70. The retinoblastoma protein and its relatives.
Whyte P
Semin Cancer Biol; 1995 Apr; 6(2):83-90. PubMed ID: 7647310
[TBL] [Abstract][Full Text] [Related]
71. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein.
Buchmann AM; Swaminathan S; Thimmapaya B
Mol Cell Biol; 1998 Aug; 18(8):4565-76. PubMed ID: 9671466
[TBL] [Abstract][Full Text] [Related]
72. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
[TBL] [Abstract][Full Text] [Related]
73. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK
Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216
[TBL] [Abstract][Full Text] [Related]
74. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
Lind EF; Wayne J; Wang QZ; Staeva T; Stolzer A; Petrie HT
J Immunol; 1999 May; 162(9):5374-9. PubMed ID: 10228014
[TBL] [Abstract][Full Text] [Related]
75. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
76. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
77. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
78. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
[TBL] [Abstract][Full Text] [Related]
79. Expression patterns of retinoblastoma and E2F family proteins during corneal development.
Francesconi CM; Hutcheon AE; Chung EH; Dalbone AC; Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1054-62. PubMed ID: 10752941
[TBL] [Abstract][Full Text] [Related]
80. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
